Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Sonja Gandhi-Banga, Anne-Laure Chabanon, Cecile Eymin, Timothy Caroe, Karina Butler & Annick Moureau. (2019) Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season. Human Vaccines & Immunotherapeutics 15:9, pages 2154-2158.
Read now
Read now
Guglielmo Dini, Alessandra Toletone, Laura Sticchi, Andrea Orsi, Nicola Luigi Bragazzi & Paolo Durando. (2018) Influenza vaccination in healthcare workers: A comprehensive critical appraisal of the literature. Human Vaccines & Immunotherapeutics 14:3, pages 772-789.
Read now
Read now
Ivan F. N. Hung & Kwok-Yung Yuen. (2018) Immunogenicity, safety and tolerability of intradermal influenza vaccines. Human Vaccines & Immunotherapeutics 14:3, pages 565-570.
Read now
Read now
Corwin A. Robertson, Carlos A. DiazGranados, Michael D. Decker, Ayman Chit, Monica Mercer & David P. Greenberg. (2016) Fluzone® High-Dose Influenza Vaccine. Expert Review of Vaccines 15:12, pages 1495-1505.
Read now
Read now
Yeu-Chun Kim, Su-Hwa Lee, Won-Hyung Choi, Hyo-Jick Choi, Tae-Won Goo, Ju-Hie Lee & Fu-Shi Quan. (2016) Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection. Journal of Drug Targeting 24:10, pages 943-951.
Read now
Read now
Nicola Luigi Bragazzi, Andrea Orsi, Filippo Ansaldi, Roberto Gasparini & Giancarlo Icardi. (2016) Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview. Human Vaccines & Immunotherapeutics 12:10, pages 2616-2627.
Read now
Read now
Corwin A. Robertson, Peter Tsang, Victoria A. Landolfi & David P. Greenberg. (2016) Fluzone® Intradermal Quadrivalent Influenza Vaccine. Expert Review of Vaccines 15:10, pages 1245-1253.
Read now
Read now
Luigi Aurisicchio, Rita Mancini & Gennaro Ciliberto. (2013) Cancer vaccination by electro-gene-transfer. Expert Review of Vaccines 12:10, pages 1127-1137.
Read now
Read now
Isabel Leroux-Roels & Françoise Weber. (2013) Intanza® 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Human Vaccines & Immunotherapeutics 9:1, pages 115-121.
Read now
Read now
Articles from other publishers (28)
Yang Yu, Ji Wang & Mei X. Wu. (2023) Microneedle-Mediated Immunization Promotes Lung CD8+ T-Cell Immunity. Journal of Investigative Dermatology 143:10, pages 1983-1992.e3.
Crossref
Crossref
Oluwaseun Egunsola, Fiona Clement, John Taplin, Liza Mastikhina, Joyce W. Li, Diane L. Lorenzetti, Laura E. Dowsett & Tom Noseworthy. (2021) Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines. JAMA Network Open 4:2, pages e2035693.
Crossref
Crossref
Antonella Conforti, Joseph Impellizeri & Luigi Aurisicchio. 2021. Electroporation in Veterinary Oncology Practice. Electroporation in Veterinary Oncology Practice
235
252
.
Akmal H. Sabri, Yujin Kim, Maria Marlow, David J. Scurr, Joel Segal, Ajay K. Banga, Leonid Kagan & Jong Bong Lee. (2020) Intradermal and transdermal drug delivery using microneedles – Fabrication, performance evaluation and application to lymphatic delivery. Advanced Drug Delivery Reviews 153, pages 195-215.
Crossref
Crossref
Akmal H. Sabri, Jane Ogilvie, Khuriah Abdulhamid, Volha Shpadaruk, John McKenna, Joel Segal, David J. Scurr & Maria Marlow. (2019) Expanding the applications of microneedles in dermatology. European Journal of Pharmaceutics and Biopharmaceutics 140, pages 121-140.
Crossref
Crossref
Golnoosh Torabian, Peter Valtchev, Qayyum Adil & Fariba Dehghani. (2019) Anti-influenza activity of elderberry (Sambucus nigra). Journal of Functional Foods 54, pages 353-360.
Crossref
Crossref
Viral Shah & Bijaya Krushna Choudhury. (2017) Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics. AAPS PharmSciTech 18:8, pages 2936-2948.
Crossref
Crossref
Takuwa Yasuda, Takehiro Ura, Masaru Taniguchi & Hisahiro Yoshida. (2016) Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy. PLOS ONE 11:12, pages e0167952.
Crossref
Crossref
J. Impellizeri, L. Aurisicchio, P. Forde & D.M. Soden. (2016) Electroporation in veterinary oncology. The Veterinary Journal 217, pages 18-25.
Crossref
Crossref
Brendan Koch, Ilaria Rubino, Fu-Shi Quan, Bongyoung Yoo & Hyo-Jick Choi. (2016) Microfabrication for Drug Delivery. Materials 9:8, pages 646.
Crossref
Crossref
Hiromasa Okayasu, Roland W. Sutter, Hamid S. Jafari, Marina Takane & R. Bruce Aylward. (2014) Affordable Inactivated Poliovirus Vaccine: Strategies and Progress. The Journal of Infectious Diseases 210:suppl_1, pages S459-S464.
Crossref
Crossref
P. Pedrazzoli, F. Baldanti, I. Donatelli, M.R. Castrucci, F. Puglisi, N. Silvestris & S. Cinieri. (2014) Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM). Annals of Oncology 25:6, pages 1243-1247.
Crossref
Crossref
Peter Tsang, Geoffrey J. Gorse, Cynthia B. Strout, Malcolm Sperling, David P. Greenberg, Ayca Ozol-Godfrey, Carlos DiazGranados & Victoria Landolfi. (2014) Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial. Vaccine 32:21, pages 2507-2517.
Crossref
Crossref
Markus Hilleringmann, Björn Jobst & Barbara C. Baudner. 2014. Molecular Vaccines. Molecular Vaccines
823
837
.
Sachiko Hirobe, Hiroaki Azukizawa, Kazuhiko Matsuo, You Zhai, Ying-Shu Quan, Fumio Kamiyama, Hiroshi Suzuki, Ichiro Katayama, Naoki Okada & Shinsaku Nakagawa. (2013) Development and Clinical Study of a Self-Dissolving Microneedle Patch for Transcutaneous Immunization Device. Pharmaceutical Research 30:10, pages 2664-2674.
Crossref
Crossref
Fu-Shi Quan, Yeu-Chun Kim, Jae-Min Song, Hye Suk Hwang, Richard W. Compans, Mark R. Prausnitz & Sang-Moo Kang. (2013) Long-Term Protective Immunity from an Influenza Virus-Like Particle Vaccine Administered with a Microneedle Patch. Clinical and Vaccine Immunology 20:9, pages 1433-1439.
Crossref
Crossref
Marc P. Girard, John S. Tam, Yuri Pervikov & Jacqueline M. Katz. (2013) Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses. Vaccine 31:37, pages 3766-3771.
Crossref
Crossref
Martina Prelog. (2013) Differential Approaches for Vaccination from Childhood to Old Age. Gerontology 59:3, pages 230-239.
Crossref
Crossref
Xuefei Shen, Jonas Söderholm, Feng Lin, Gary Kobinger, Alexander Bello, Derek A. Gregg, Kate E. Broderick & Niranjan Y. Sardesai. (2012) Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model. Vaccine 30:48, pages 6946-6954.
Crossref
Crossref
Yeu-Chun Kim, Jung-Hwan Park & Mark R. Prausnitz. (2012) Microneedles for drug and vaccine delivery. Advanced Drug Delivery Reviews 64:14, pages 1547-1568.
Crossref
Crossref
Brenda L. Coleman, Allison J. McGeer, Scott A. Halperin, Joanne M. Langley, Yassein Shamout, Anna Taddio, Vibhuti Shah & Shelly A. McNeil. (2012) A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine. Vaccine 30:44, pages 6287-6293.
Crossref
Crossref
Simon Oakley. (2012) Patient acceptability of intradermal influenza vaccine. Practice Nursing 23:6, pages 296-300.
Crossref
Crossref
Maria del Pilar Martin, William C. Weldon, Vladimir G. Zarnitsyn, Dimitrios G. Koutsonanos, Hamed Akbari, Ioanna Skountzou, Joshy Jacob, Mark R. Prausnitz & Richard W. Compans. (2012) Local Response to Microneedle-Based Influenza Immunization in the Skin. mBio 3:2.
Crossref
Crossref
Filippo Ansaldi, Paola Canepa, Antonella Ceravolo, Laura Valle, Daniela de Florentiis, Raymond Oomen, Frederick R. Vogel, Martine Denis, Sandrine I. Samson & Giancarlo Icardi. (2012) Intanza? 15mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses. Vaccine 30:18, pages 2908-2913.
Crossref
Crossref
Paolo Durando, Cristiano Alicino, Marisa Alberti, Laura Sticchi, Valter Turello, Lorenzo Marensi, Anna Luisa Caiazzo, Maria Grazia Panico, Francesco Giugliano, Antonino Parlato, Filomena Peluso, Stefano Sgricia & Giancarlo Icardi. (2012) Acceptance and Safety of the Intradermal Influenza Vaccine Among the Elderly in Italy: an On-Field National Study. Advances in Therapy 29:4, pages 312-326.
Crossref
Crossref
Ronald J PettisAlfred J Harvey. (2012) Microneedle delivery: clinical studies and emerging medical applications. Therapeutic Delivery 3:3, pages 357-371.
Crossref
Crossref
Anushree Herwadkar & Ajay K Banga. (2012) An update on the application of physical technologies to enhance intradermal and transdermal drug delivery. Therapeutic Delivery 3:3, pages 339-355.
Crossref
Crossref
Shabnam Alam & Andrea J. Sant. (2011) Infection with Seasonal Influenza Virus Elicits CD4 T Cells Specific for Genetically Conserved Epitopes That Can Be Rapidly Mobilized for Protective Immunity to Pandemic H1N1 Influenza Virus. Journal of Virology 85:24, pages 13310-13321.
Crossref
Crossref